Home » News » CIPHE France
Just one month after its official start, PRIM-TECH3R kicked off with energy and one clear direction. Over the next four years, this EU-funded project will drive innovation in preclinical in vitro models, advancing the 3Rs and reshaping biomedical research across Europe.
A new publication of INFRAFRONTIER in Mammalian Genome is available on line now. Get an overview of the latest INFRAFRONTIER advancements, including services, resources, and technical developments.
The interest in the scientific community to fight the pandemic using mouse models is remarkably high. In December 2020, INFRAFONTIER launched an attractive free-of-charge service for the biomedical research community fighting against the COVID-19 pandemic: The COVID-19 Therapeutics Pipeline Trans-national Access (TA) Call offered academic researchers to test their novel therapeutics and vaccine candidates in a preclinical Bio-Safety Level 3 (BSL3) pipeline using COVID-19 optimized mouse models
It´s a unique training event for of all kinds of biomedial scientists working with mouse models – held in a fascinating location: The bi-annually organized European Advanced School for Mouse Phenogenomics, taking place on 20 to 24 May 2019 near Strasbourg, offers an overview of up-to-date methods and good practices for the use of mouse models in scientific research that cannot be found anywhere else in Europe.
In a formal act authenticated by a notary in Munich, four founding members acquired shares of the INFRAFRONTIER GmbH: the Centre National de la Recherche Scientifique (CNRS) from France, the Biomedical Sciences Research Center ‘Alexander Fleming’ from Greece, the Institute of Molecular Genetics of the Acedemy of Sciences of the Czech Republic, and the University of Oulu in Finland.
